Skip to main content
Publish date:

ORGO INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors With Losses To Inquire About Class Action Investigation - ORGO

NEW YORK, Oct. 18, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Organogenesis Holdings Inc.

NEW YORK, Oct. 18, 2021 /PRNewswire/ --

WHY:Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Organogenesis Holdings Inc. (ORGO) - Get Organogenesis Holdings, Inc. Class A Report resulting from allegations that Organogenesis may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Organogenesis securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT:To join the prospective class action, go to http://www.rosenlegal.com/cases-register-2177.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

WHAT IS THIS ABOUT: On October 12, 2021, Value Investors Club issued a report alleging issues at Organogenesis, indicating that the Company has been improperly billing the federal government for $250 million annually. The Company also set the price for its new wound covering, Affinity, "exorbitantly high[,]" which Medicare reimbursed, while making the product lucrative for doctors to use through large rebates.

On this news, Organogenesis shares fell $1.70, or 14%, to close at $10.35 per share on October 12, 2021, damaging investors.

WHY ROSEN LAW:We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.      Phillip Kim, Esq.      The Rosen Law Firm, P.A.      275 Madison Avenue, 40th Floor      New York, NY 10016      Tel: (212) 686-1060      Toll Free: (866) 767-3653      Fax: (212) 202-3827      lrosen@rosenlegal.com      pkim@rosenlegal.com      cases@rosenlegal.com      www.rosenlegal.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/orgo-investor-notice-rosen-leading-investor-counsel-encourages-organogenesis-holdings-inc-investors-with-losses-to-inquire-about-class-action-investigation--orgo-301402797.html

SOURCE Rosen Law Firm, P.A.